Corvus Pharmaceuticals Inc (CRVS) returns
Corvus Pharmaceuticals returns over 10 years
$1,000 invested in Corvus Pharmaceuticals ten years ago was worth $735.88 at the close on October 30, 2026, with dividends reinvested: an average return of -3.0% a year. The same $1,000 in the S&P 500 (SPY) became $4,166.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | -12.9% | — | $870.66 | -0.9% |
| 3 months | -24.0% | — | $760.43 | +2.1% |
| Year to date | +30.3% | — | $1,303 | +11.7% |
| 1 year | +29.3% | — | $1,293 | +12.4% |
| 3 years | +828.7% | +110.2% | $9,287 | +88.5% |
| 5 years | +121.4% | +17.2% | $2,214 | +76.0% |
| 10 years | -26.4% | -3.0% | $735.88 | +316.6% |
Corvus Pharmaceuticals return by calendar year
| Year | CRVS | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | +30.3% | +11.7% | +18.6% |
| 2025 | +43.9% | +17.7% | +26.2% |
| 2024 | +204.0% | +24.9% | +179.1% |
| 2023 | +107.1% | +26.2% | +80.9% |
| 2022 | -64.7% | -18.2% | -46.6% |
| 2021 | -32.3% | +28.7% | -61.0% |
| 2020 | -34.6% | +18.4% | -52.9% |
| 2019 | +48.2% | +31.2% | +17.0% |
| 2018 | -64.6% | -4.6% | -60.0% |
| 2017 | -27.6% | +21.7% | -49.3% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Corvus Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.